About Nerviano Medical Sciences
Nerviano Medical Sciences is the largest independent company for the research and development of cancer-fighting drugs in Europe and is wholly owned by the Rome-based Congregazione dei Figli dell'Immacolata Concezione.
NMS enters into strategic alliances with biotechnology and pharmaceutical companies for the discovery and development of innovative cancer therapies to ensure the long-term sustainability of the company.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
News about Nerviano Medical Sciences
Here you will find Nerviano Medical Sciences S.r.l
Last viewed contents
Evonik is investing in NUMAFERM - Start-up makes the production of peptides more efficient
Foods rich in resistant starch may benefit health
New method reveals how the Parkinson's disease protein damages cell membranes - The method makes it possible to study tiny quantities of biological molecules without using fluorescent markers
Category:Rifamycin_antibiotics
CellSpring AG - Zürich, Switzerland
Out_of_the_Shadow_(TV_show)
Agenesis_of_the_corpus_callosum
Category:Halogen-containing_natural_products
Octarine Bio - Copenhagen, Denmark
POWTECH TECHNOPHARM 2025: three days packed with innovation, discussions and inspiration
